The Role of Probiotics in Preventing Recurrent Urinary Tract Infections in Pregnant Women

The Role of Probiotics in Preventing Recurrent Urinary Tract Infections in Pregnant Women: A Randomized Control Trial

Urinary tract infections (UTIs) are a significant public health problem affecting more than 150 million people worldwide and causing a significant economic impact of approximately US$ 6 billion annually. It is one of the most common infectious diseases after upper respiratory tract infections. More than 50% of women and at least 12% of men will be affected by urinary tract infections in their lifetime. The probiotic supplement was delivered as easy-to-swallow capsules specifically prepared to maintain the viability and stability of the Lactobacillus rhamnosus GG strain throughout the research period. Participants were told to take the probiotic supplement with water to maximise absorption and efficiency, ideally after meals.

Inclusion Criteria:

• Pregnant women aged 18-40 year
• History of recurrent urinary tract infections (two or more episodes in the past year).
• Singleton pregnancy.

Exclusion Criteria:

• Multiple gestations.
• History of preterm labor.
• Chronic medical conditions (e.g., diabetes mellitus, immunodeficiency disorders).
• Use of antibiotics or probiotics within the past month.